Menu
Menu
Which PLA code was added for bulk acoustic wave (BAW) biosensor immunoassay for SARS-CoV-2 (Coronavirus disease [COVID-19]) in the 2024 AMA CPT® Manual?
The following PLA code was added for bulk acoustic wave (BAW) biosensor immunoassay for SARS-CoV-2 (Coronavirus disease [COVID-19]), having become effective on October 1, 2023, but appearing in the 2024 AMA CPT Manual as a new code 0408U (Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]). This test evaluates a nasal swab specimen using an automated instrument that implements an immunoassay procedure and BAW biosensor to detect antigens related to COVID–19.
This question was answered in our Coding Essentials for Laboratories. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2023 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2024 MedLearn Publishing. Powered by MedLearn Media.
Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’ is just $99 for a limited time! Use code WorldHealth24 at checkout.